ArticleOpen forum infectious diseases2025
Trends in Mortality Among People With HIV in Mexico: Analysis of National Death Registries (1998-2022).
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Caribbean, Central and South America Network for HIV Epidemiology: 20 Years of HIV Research in the Region.Journal of the International AIDS Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: We aimed to describe the frequency of deaths related to advanced HIV disease (AHD) and its associated characteristics, as well as the frequency of very early and early mortality after HIV diagnosis, among people with HIV in Mexico between 1998 and 2022. Methods: We used data from the Mexican National Death Registry. We defined deaths related to AHD as those listed in the AIDS-defining conditions of the Centers for Disease Control and Prevention, very early mortality as deaths occurring within the first month after HIV diagnosis, and early mortality as those occurring between the first month and the first year after HIV diagnosis. We used logistic regression models to describe trends of deaths related to AHD, early mortality, very early mortality, and specific causes of death over time. Results: There were 106 056 registered deaths among people with HIV, ranging from 507 to 5287 annually. The most common cause of death was related to AHD throughout the study period (54%). The predicted probability of death related to AHD decreased from 75% to 35% between 2000 and 2012 but increased after 2014 to 52% in 2022. Overall, 22% of deaths occurred very early and 25% early after HIV diagnosis. Calendar year was the only strong predictor of death due to AHD. Conclusions: A high and increasing proportion of deaths were attributed to advanced HIV disease in Mexico; a fifth of them occurred in the first month of HIV diagnosis and almost a half in the first year. In the context of universal access to antiretroviral therapy, these results suggest that additional components of the public health HIV response could be lacking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.